Knowledge, uptake and therapeutic effectiveness of sulfadoxine-pyrimethamine (IPTp-SP) among pregnant women attending the antenatal clinic at ayeduase Health Centre in Oforikrom Municipality in the Ashanti-region, Ghana.

Background: Malaria is a life-threatening disease, and in pregnancy, it has been recognized to pose a substantial threat to mothers, fetuses and neonates and accounted for 249 million malaria cases and 608,000 malaria deaths in 85 countries in 2022. Malaria in pregnancy poses a significant threat, and globally, it is associated with approximately 10,000 maternal deaths each year. In sub-Saharan Africa, it is projected that approximately 25 million pregnant women in this region are at risk of contracting Plasmodium falciparum malaria infection annually.